BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9591597)

  • 1. Transferrin-dependent uptake and dosimetry of Auger-emitting diagnostic radionuclides in human spermatozoa.
    Hoyes KP; Nettleton JS; Lawson RS; Morris ID
    J Nucl Med; 1998 May; 39(5):895-9. PubMed ID: 9591597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferrin-mediated uptake of radionuclides by the testis.
    Hoyes KP; Morris ID; Hendry JH; Sharma HL
    J Nucl Med; 1996 Feb; 37(2):336-40. PubMed ID: 8667073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [99mTc reduces clonogenic survival after intracellular uptake in NIS-positive cells in vitro more than 131I].
    Wendisch M; Freudenberg R; Drechsel J; Runge R; Wunderlich G; Kotzerke J
    Nuklearmedizin; 2010; 49(4):154-60. PubMed ID: 20490428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on cell survival, induction of apoptosis and micronucleus formation in SCL-II cells after exposure to the auger electron emitter (99m)Tc.
    Kriehuber R; Kadenbach K; Schultz F; Weiss DG
    Int J Radiat Biol; 2004; 80(11-12):875-80. PubMed ID: 15764396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation damage to mouse testis cells from [99mTc] pertechnetate.
    Mian TA; Suzuki N; Glenn HJ; Haynie TP; Meistrich ML
    J Nucl Med; 1977 Nov; 18(11):1116-22. PubMed ID: 915090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides.
    Boyd M; Ross SC; Dorrens J; Fullerton NE; Tan KW; Zalutsky MR; Mairs RJ
    J Nucl Med; 2006 Jun; 47(6):1007-15. PubMed ID: 16741311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effects of iron-55 and iron-59 on mouse testes: biophysical dosimetry of Auger electrons.
    Rao DV; Sastry KS; Govelitz GF; Grimmond HE; Hill HZ
    J Nucl Med; 1985 Dec; 26(12):1456-65. PubMed ID: 4067645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emitters.
    Govindan SV; Goldenberg DM; Elsamra SE; Griffiths GL; Ong GL; Brechbiel MW; Burton J; Sgouros G; Mattes MJ
    J Nucl Med; 2000 Dec; 41(12):2089-97. PubMed ID: 11138697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Auger electron dosimetry of indium-111 in mammalian cells in vitro.
    McLean JR; Blakey DH; Douglas GR; Bayley J
    Radiat Res; 1989 Aug; 119(2):205-18. PubMed ID: 2756113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of the mechanism of action of nitrogen monoxide on iron uptake from transferrin.
    Watts RN; Richardson DR
    J Lab Clin Med; 2000 Aug; 136(2):149-56. PubMed ID: 10945243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy using antisense oligodeoxynucleotides labeled with Auger-emitting radionuclides.
    Kairemo KJ; Tenhunen M; Jekunen AP
    Cancer Gene Ther; 1998; 5(6):408-12. PubMed ID: 9917096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake, localization, and dosimetry of 111in and 201tl in human testes.
    Nettleton JS; Lawson RS; Prescott MC; Morris ID
    J Nucl Med; 2004 Jan; 45(1):138-46. PubMed ID: 14734686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity of some indium radiopharmaceuticals in mouse testes.
    Rao DV; Sastry KS; Grimmond HE; Howell RW; Govelitz GF; Lanka VK; Mylavarapu VB
    J Nucl Med; 1988 Mar; 29(3):375-84. PubMed ID: 3126279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monte Carlo single-cell dosimetry of Auger-electron emitting radionuclides.
    Bousis C; Emfietzoglou D; Hadjidoukas P; Nikjoo H
    Phys Med Biol; 2010 May; 55(9):2555-72. PubMed ID: 20393237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The assessment and management of risks associated with exposures to short-range Auger- and beta-emitting radionuclides. State of the art and proposals for lines of research.
    Paquet F; Barbey P; Bardiès M; Biau A; Blanchardon E; Chetioui A; Lebaron-Jacobs L; Pasquier JL
    J Radiol Prot; 2013 Mar; 33(1):R1-16. PubMed ID: 23296029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-(125I)-iododeoxyuridine and the Auger effect: biological consequences and implications for therapy.
    Bloomer WD; Adelstein SJ
    Pathobiol Annu; 1978; 8():407-21. PubMed ID: 364377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using auger electron emitters.
    Ginj M; Hinni K; Tschumi S; Schulz S; Maecke HR
    J Nucl Med; 2005 Dec; 46(12):2097-103. PubMed ID: 16330576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of conventional internal dosimetry at the cellular level.
    Makrigiorgos GM; Adelstein SJ; Kassis AI
    J Nucl Med; 1989 Nov; 30(11):1856-64. PubMed ID: 2809750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioisotopic Purity of Sodium Pertechnetate 99mTc Produced with a Medium-Energy Cyclotron: Implications for Internal Radiation Dose, Image Quality, and Release Specifications.
    Selivanova SV; Lavallée É; Senta H; Caouette L; Sader JA; van Lier EJ; Zyuzin A; van Lier JE; Guérin B; Turcotte É; Lecomte R
    J Nucl Med; 2015 Oct; 56(10):1600-8. PubMed ID: 26205300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.